Vivani Medical (VANI) Operating Expenses (2014 - 2026)
Vivani Medical (VANI) posted quarterly Operating Expenses of $6.8 million for Q1 2026, up 3.97% year-over-year from $6.6 million in Q1 2025, and little changed quarter-over-quarter from $6.8 million in Q4 2025.
Vivani Medical (VANI) Operating Expenses (2014 - 2026) Analysis & Trends
Vivani Medical's Operating Expenses history runs 12 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 3.97% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $27.8 million (up 11.22% YoY), while the FY2025 annual figure was $27.6 million, up 11.67% from the prior year.
- Operating Expenses for Q1 2026 stood at $6.8 million, roughly flat from $6.8 million in the prior quarter.
- The five-year high for Operating Expenses was $7.8 million in Q4 2022, with the low at $3.9 million in Q1 2022.
- The 5-year median for Operating Expenses is $6.6 million (2025), against an average of $6.3 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 119.56% in 2022, then slipped 20.19% in 2023.
- Vivani Medical's Operating Expenses stood at $7.8 million in 2022, then slipped by 20.19% to $6.2 million in 2023, then grew by 3.91% to $6.5 million in 2024, then rose by 5.42% to $6.8 million in 2025, then climbed by 0.1% to $6.8 million in 2026.
- Business Quant data shows VANI's Operating Expenses at $6.8 million in Q1 2026, $6.8 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 541.02 Mn |
| 10 | Vivani Medical | 122.36 Mn | 102.47 Mn | - | 6.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.87 Mn |
| Mar 31, 2026 | 6.82 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 7.46 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Dec 31, 2024 | 6.46 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Mar 31, 2024 | 6.23 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 7.14 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 6.60 Mn |
| Dec 31, 2022 | 7.79 Mn |
| Sep 30, 2022 | 5.44 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 3.91 Mn |
| Dec 31, 2021 | 3.55 Mn |
| Sep 30, 2021 | 3.49 Mn |